| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.8 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |